CEO of Zdravlje A.D. and Founder of Frontier Pharma, UK
Kiren Naidoo is the Chief Executive Officer and Board Member of Zdravlje A.D., one of the largest pharmaceutical manufacturers in the region. Kiren represents Frontier Baystone, Zdravlje’s shareholders, which is a London-based specialized healthcare investor. Previously, Kiren was an investment banker at Bank of America Merrill Lynch (BofAML), specialising in mergers & acquisitions (M&A) and financing projects within the pharmaceutical industry. During his time at BofAML Kiren advised and executed over $50 billion in transactions across the US, Europe, CEE, Middle East and Africa.
14:30 - 15:30
Academia session: Biotechnology - How is it shaping our future?
Moderator and chair of the session: Dr. Jelena Begović, Director of Institute of Molecular Genetics and Genetic Engineering (IMGGE) and Full Research Professor
Business session: Accelerating innovation
Moderator and chair of the session: Prof. Robert C. Wolcott, Co-Founder and Chairman of The World Innovation Network (TWIN) and Adjunct Professor of Innovation at Booth School of Business at University of Chicago & Kellogg School of Management at Northwestern University